1 – 5 of 5
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1 : a substudy of the NEAT001/ANRS143 randomised trial
(
- Contribution to journal › Article
-
Mark
Virological Response and Antiretroviral Drug Resistance Emerging during Antiretroviral Therapy at Three Treatment Centers in Uganda
(
- Contribution to journal › Article
- 2014
-
Mark
Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1 : 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial
(
- Contribution to journal › Article
-
Mark
The arrival of untreatable multidrug-resistant HIV-1 in sub-Saharan Africa
(
- Contribution to journal › Article
- 2010
-
Mark
Challenges and perspectives for improved management of HIV/Mycobacterium tuberculosis co-infection
(
- Contribution to journal › Article